Argon laser trabeculoplasty with standard and long duration

Area of Science:

• Ophthalmology
• Glaucoma Research
• Laser Therapy

Background:

• Chronic simple glaucoma is a leading cause of irreversible blindness.
• Argon laser trabeculoplasty is a common treatment to reduce intraocular pressure.
• Optimizing laser parameters is crucial for treatment efficacy and patient comfort.

Purpose of the Study:

• To compare the efficacy and patient comfort of two different argon laser trabeculoplasty durations (0.1 sec vs. 0.2 sec) in chronic simple glaucoma.
• To evaluate the impact of laser duration on intraocular pressure reduction and glaucoma control.
• To assess patient-reported discomfort associated with different laser exposure times.

Main Methods:

• A prospective, randomized study involving 33 patients with chronic simple glaucoma.
• Each patient received 0.1-second laser trabeculoplasty in one eye and 0.2-second in the fellow eye.
• Intraocular pressure and glaucoma control were monitored over a six-month period.

Main Results:

• No significant difference was observed in intraocular pressure reduction between the 0.1-sec and 0.2-sec laser durations.
• Glaucoma control was comparable between the two treatment groups over the six-month follow-up.
• Sixty percent of patients reported greater discomfort with the 0.2-second argon laser trabeculoplasty compared to the 0.1-second duration.

Conclusions:

• Argon laser trabeculoplasty duration (0.1 sec vs. 0.2 sec) does not influence its efficacy in managing chronic simple glaucoma.
• The 0.1-second duration offers a comparable therapeutic outcome with improved patient comfort.
• Shorter laser exposure times may be preferable for enhancing patient tolerance during trabeculoplasty procedures.